<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/F25BC0C5-5284-441F-B79F-A61707946CA0"><gtr:id>F25BC0C5-5284-441F-B79F-A61707946CA0</gtr:id><gtr:name>University of California Los Angeles</gtr:name><gtr:address><gtr:line1>405 Hillgard Avenue</gtr:line1><gtr:line2>Box 951361</gtr:line2><gtr:postCode>90095</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/E1649C06-DC81-4A08-8A23-F5B65BB6C670"><gtr:id>E1649C06-DC81-4A08-8A23-F5B65BB6C670</gtr:id><gtr:name>Babraham Institute</gtr:name><gtr:department>Epigenetics</gtr:department><gtr:address><gtr:line1>Babraham Research Campus</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:line5>Cambridgeshire</gtr:line5><gtr:postCode>CB22 3AT</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/E1649C06-DC81-4A08-8A23-F5B65BB6C670"><gtr:id>E1649C06-DC81-4A08-8A23-F5B65BB6C670</gtr:id><gtr:name>Babraham Institute</gtr:name><gtr:address><gtr:line1>Babraham Research Campus</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:line5>Cambridgeshire</gtr:line5><gtr:postCode>CB22 3AT</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/F25BC0C5-5284-441F-B79F-A61707946CA0"><gtr:id>F25BC0C5-5284-441F-B79F-A61707946CA0</gtr:id><gtr:name>University of California Los Angeles</gtr:name><gtr:address><gtr:line1>405 Hillgard Avenue</gtr:line1><gtr:line2>Box 951361</gtr:line2><gtr:postCode>90095</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/0CEC6E19-2999-49FF-95D0-6A682CEB301E"><gtr:id>0CEC6E19-2999-49FF-95D0-6A682CEB301E</gtr:id><gtr:firstName>Wolf</gtr:firstName><gtr:surname>Reik</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0700098"><gtr:id>138861F3-7CA6-4CB7-A414-3F32D8AAAFDA</gtr:id><gtr:title>Role of cytidine deaminases in epigenetic reprogramming and demethylation of DNA</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0700098</gtr:grantReference><gtr:abstractText>All genes in the genome of humans and other mammals are now known. However we have little knowledge about which signals are needed for genes to switch on and off during development of a new organism from embryo to adult. An important signal are instructions that are attached to DNA in the form of small chemical molecules (methyl-groups). These are usually attached to genes when they need to be off. When genes need to be switched on, the methyl-groups need to be removed from the DNA; this is particularly important at the beginning of development in the very early embryo. When this switching is defective it can give rise to diseases of embryonic development and many cancers have aberrant ?epigenetic? switching of this type. Our current work has identified a mechanism for the removal of the methyl-signals from DNA, and in work under this grant we will gain a better understanding how this mechanism works in embryos, in order to harness its activities for stem cell ?regenerative? medicine and cures for cancer.</gtr:abstractText><gtr:technicalSummary>DNA methylation of CpG dinucleotides is an important mechanism of epigenetic regulation of genome function in mammals, and has key roles in genomic imprinting, X chromosome inactivation, silencing of transposons, genome stability, and developmental gene expression. Aberrant regulation of DNA methylation is implicated in many human diseases, particularly cancers. DNA methylation is reprogrammed genome wide in the zygote and preimplantation embryo, and in primordial germ cells. Reprogramming involves active demethylation, and is important for the erasure of genomic imprints, and likely for the return of the embryonic genome to totipotency. We have shown that cytidine deaminases such as Aid and Apobec1 can deaminate 5 methylcytosine (5meC) in DNA, leading to T:G mismatches which can be repaired by the base excision repair pathway. These genes are part of a pluripotency gene cluster and are expressed in oocytes and germ cells in which demethylation occurs. We have recently targeted Aid in transgenic mice to a highly methylated region of the genome, and find that this region is efficiently and substantially (approx 90%) demethylated without incurring sequence mutations. Preliminary work shows that Aid deficient zygotes have a deficit in the demethylation of the paternal genome. Having obtained proof-of-principle evidence that Aid can initiate demethylation in vivo, we are now building upon this work to fully understand the mechanisms involved as well as the physiological relevance. The aim of the proposed work is to elucidate in depth the role of Aid/Apobec family deaminases in epigenetic reprogramming and demethylation of DNA in vivo. The specific objectives are 1. the full characterisation of the gain-of-function experiments in which Aid and Apobec1 are targeted to methylated regions in the mouse genome in vivo 2. the characterisation of the pathways downstream of Aid which resolve base mismatches, using Xrcc1 and TDG conditional knockouts 3. the completion of a conditional Aid-Apobec1 knockout, followed by phenotypic characterisation and its combination with Apobec2 and -3 knockouts and 4. the analysis of endogenous DNA methylation including by methylDIP in these knockouts. This work will not only elucidate the mechanisms of epigenetic reprogramming and demethylation, but it will also have direct applications in regenerative medicine and cancer therapy approaches, some of which are already being persued in industrial collaborations.</gtr:technicalSummary><gtr:fund><gtr:end>2012-01-01</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-01-02</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>943127</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Cambridge Institute for Medical Research (CIMR)</gtr:department><gtr:description>MRC EASIH</gtr:description><gtr:id>139D89CD-BCE0-4D83-80D9-1526A510EB4F</gtr:id><gtr:impact>see above</gtr:impact><gtr:partnerContribution>MRC East Anglia Sequencing and Informatics Hub established in 2009</gtr:partnerContribution><gtr:piContribution>increased opportunities for deep sequencing using alternative platforms such as Roche 454 and ABI Solid</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Sanger Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Sanger</gtr:description><gtr:id>FDDC9D95-FD82-4618-8002-20A69DED3BA9</gtr:id><gtr:impact>Leading to Associate Faculty Position at Sanger Institute</gtr:impact><gtr:partnerContribution>Leading to Associate Faculty Position at Sanger Institute</gtr:partnerContribution><gtr:piContribution>Leading to Associate Faculty Position at Sanger Institute</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of California, Los Angeles (UCLA)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>BS-Seq with Steve Jacobsen's lab</gtr:description><gtr:id>E805035C-B92B-4D3C-B35D-3BB9AD78EECC</gtr:id><gtr:impact>see above, a manuscript is under review</gtr:impact><gtr:partnerContribution>Exchange of technologies and reagents</gtr:partnerContribution><gtr:piContribution>We carried out deep sequencing of DNA methylation in germ cells and other reprogramming tissues</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Cheltenham Science Festival</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>9604B7BD-1B2D-40BA-AFBC-E6BAA904D0B6</gtr:id><gtr:impact>A panel discussion and public debate on epigenetics at the Cheltenham Science Festival 2013

Several enquiries from members of the public who attended</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.cheltenhamfestivals.com/science/whats-on/2013/flexible-inheritance-epigenetic-effects-on-health/</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>2900000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Senior Investigator Award</gtr:description><gtr:end>2018-08-02</gtr:end><gtr:fundingOrg>The Wellcome Trust Ltd</gtr:fundingOrg><gtr:id>DA4A0BED-C776-4F22-8EC5-C1E1140DCD03</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>960000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Collaboration Grant (deep sequencing in Epigenomics)</gtr:description><gtr:end>2013-04-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>95FCBF58-BED5-4AF6-A5A8-F9205C204959</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-05-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>We found that targeting the deaminase Aid to specific regions in the mouse genome can lead to their demethylation</gtr:description><gtr:id>CF7A03F8-6C05-4492-BF75-559A54DB0777</gtr:id><gtr:impact>new BBSRC LINK grant in this area together with commercial partner CellCentric</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:patentId>WO2007128982</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>Targeted demethylation by AID</gtr:title><gtr:yearProtectionGranted>2007</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>International Human Epigenome Consortium</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>1FC51374-79C5-4272-80C9-006770F9558A</gtr:id><gtr:impact>International Human Epigenome Consortium was launched in 2011 with significant input from the MRC community including ourselves.</gtr:impact><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Several large epigenome datasets</gtr:description><gtr:id>4F6E0DBF-75CD-411F-86CA-5C9F80F6A8E6</gtr:id><gtr:impact>Publications from other teams using our datasets</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Epigenome datasets</gtr:title><gtr:type>Database/Collection of Data/Biological Samples</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Whole genome bisulfite sequencing datasets from various mouse tissues</gtr:description><gtr:id>F2F6ED96-1AA7-40CA-B88E-9EFFA1ED3D63</gtr:id><gtr:impact>None yet</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Whole genome bisulfite sequencing</gtr:title><gtr:type>Database/Collection of Data/Biological Samples</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A0569614-C4EC-4E7E-908F-2754860E8163"><gtr:id>A0569614-C4EC-4E7E-908F-2754860E8163</gtr:id><gtr:title>Incomplete methylation reprogramming in SCNT embryos.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4d7042a898ae06c50fbe9c20801c841f"><gtr:id>4d7042a898ae06c50fbe9c20801c841f</gtr:id><gtr:otherNames>Peat JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/29EDD7AA-CECF-4297-9A7E-4FAA09F27D99"><gtr:id>29EDD7AA-CECF-4297-9A7E-4FAA09F27D99</gtr:id><gtr:title>Germline mutation in NLRP2 (NALP2) in a familial imprinting disorder (Beckwith-Wiedemann Syndrome).</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0c984efdac34b58497e7b0f51d6d10eb"><gtr:id>0c984efdac34b58497e7b0f51d6d10eb</gtr:id><gtr:otherNames>Meyer E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/23FFC4E3-A422-419F-9593-0C604D510649"><gtr:id>23FFC4E3-A422-419F-9593-0C604D510649</gtr:id><gtr:title>Global mapping of DNA methylation in mouse promoters reveals epigenetic reprogramming of pluripotency genes.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d39580750d8aa8188a148266dd9ebca6"><gtr:id>d39580750d8aa8188a148266dd9ebca6</gtr:id><gtr:otherNames>Farthing CR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D70057B5-ADDB-4E31-8A8B-1DF8BC9080EE"><gtr:id>D70057B5-ADDB-4E31-8A8B-1DF8BC9080EE</gtr:id><gtr:title>Active demethylation in mouse zygotes involves cytosine deamination and base excision repair.</gtr:title><gtr:parentPublicationTitle>Epigenetics &amp; chromatin</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3a2baed34e507aed3a886e243596924d"><gtr:id>3a2baed34e507aed3a886e243596924d</gtr:id><gtr:otherNames>Santos F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1756-8935</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1084D3FF-ED36-42F0-ADE1-17AE7494B8C3"><gtr:id>1084D3FF-ED36-42F0-ADE1-17AE7494B8C3</gtr:id><gtr:title>Conceptual links between DNA methylation reprogramming in the early embryo and primordial germ cells.</gtr:title><gtr:parentPublicationTitle>Current opinion in cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c5499f12f4aadb6cb6c1667b0db154b1"><gtr:id>c5499f12f4aadb6cb6c1667b0db154b1</gtr:id><gtr:otherNames>Seisenberger S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0955-0674</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4FC33E85-856F-4420-9174-85919172D23A"><gtr:id>4FC33E85-856F-4420-9174-85919172D23A</gtr:id><gtr:title>Reprogramming by cell fusion: boosted by Tets.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/dec6cf848835dc1cbdbd7ef7bee2cd34"><gtr:id>dec6cf848835dc1cbdbd7ef7bee2cd34</gtr:id><gtr:otherNames>Ficz G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5775C271-6894-4D8B-8274-E5C92EA669F5"><gtr:id>5775C271-6894-4D8B-8274-E5C92EA669F5</gtr:id><gtr:title>DNA demethylases: a new epigenetic frontier in drug discovery.</gtr:title><gtr:parentPublicationTitle>Drug discovery today</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/742a6355de110b9584a2adba20e667a8"><gtr:id>742a6355de110b9584a2adba20e667a8</gtr:id><gtr:otherNames>Carey N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1359-6446</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F1302D6B-59FD-425E-8199-8B1665AF13ED"><gtr:id>F1302D6B-59FD-425E-8199-8B1665AF13ED</gtr:id><gtr:title>Epigenetic reprogramming in plant and animal development.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bdcd498102eb22dfb2cb902ab8beea9b"><gtr:id>bdcd498102eb22dfb2cb902ab8beea9b</gtr:id><gtr:otherNames>Feng S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4B99FFE6-8364-4D0D-9605-4CAC5B95E8C0"><gtr:id>4B99FFE6-8364-4D0D-9605-4CAC5B95E8C0</gtr:id><gtr:title>Etoposide induces nuclear re-localisation of AID.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8885efadf315b3f8c2c6fcdca8401cfd"><gtr:id>8885efadf315b3f8c2c6fcdca8401cfd</gtr:id><gtr:otherNames>Lambert LJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B0B5DF97-E75F-4038-B99A-BC7306DF96D5"><gtr:id>B0B5DF97-E75F-4038-B99A-BC7306DF96D5</gtr:id><gtr:title>Safeguarding parental identity: Dnmt1 maintains imprints during epigenetic reprogramming in early embryogenesis.</gtr:title><gtr:parentPublicationTitle>Genes &amp; development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d2d5a73be80a81960b21111c9c36c85e"><gtr:id>d2d5a73be80a81960b21111c9c36c85e</gtr:id><gtr:otherNames>Branco MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0890-9369</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/650E2099-0253-48E9-A111-73753406AD78"><gtr:id>650E2099-0253-48E9-A111-73753406AD78</gtr:id><gtr:title>Retrotransposons and germ cells: reproduction, death, and diversity.</gtr:title><gtr:parentPublicationTitle>F1000 biology reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c5499f12f4aadb6cb6c1667b0db154b1"><gtr:id>c5499f12f4aadb6cb6c1667b0db154b1</gtr:id><gtr:otherNames>Seisenberger S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1757-594X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/173D4C53-4E05-4D8D-B6EC-4AFBB36D3B40"><gtr:id>173D4C53-4E05-4D8D-B6EC-4AFBB36D3B40</gtr:id><gtr:title>Reprogramming DNA methylation in the mammalian life cycle: building and breaking epigenetic barriers.</gtr:title><gtr:parentPublicationTitle>Philosophical transactions of the Royal Society of London. Series B, Biological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c5499f12f4aadb6cb6c1667b0db154b1"><gtr:id>c5499f12f4aadb6cb6c1667b0db154b1</gtr:id><gtr:otherNames>Seisenberger S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0962-8436</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A3E4E302-D585-47FC-80F5-389316B6025C"><gtr:id>A3E4E302-D585-47FC-80F5-389316B6025C</gtr:id><gtr:title>DNA demethylation by DNA repair.</gtr:title><gtr:parentPublicationTitle>Trends in genetics : TIG</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/37f635afd69f0b59351328d30cc4a385"><gtr:id>37f635afd69f0b59351328d30cc4a385</gtr:id><gtr:otherNames>Gehring M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0168-9525</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0724B709-B7F6-41C2-8F70-CF6DDF85B634"><gtr:id>0724B709-B7F6-41C2-8F70-CF6DDF85B634</gtr:id><gtr:title>Genome-wide erasure of DNA methylation in mouse primordial germ cells is affected by AID deficiency.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/eae3a38a1f3f2b731fa4eac610182beb"><gtr:id>eae3a38a1f3f2b731fa4eac610182beb</gtr:id><gtr:otherNames>Popp C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/615E3A4C-011D-4C97-B945-C63B24A39E9A"><gtr:id>615E3A4C-011D-4C97-B945-C63B24A39E9A</gtr:id><gtr:title>The dynamics of genome-wide DNA methylation reprogramming in mouse primordial germ cells.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c5499f12f4aadb6cb6c1667b0db154b1"><gtr:id>c5499f12f4aadb6cb6c1667b0db154b1</gtr:id><gtr:otherNames>Seisenberger S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/858C30BB-CD86-439C-91A9-D6F4832AB35F"><gtr:id>858C30BB-CD86-439C-91A9-D6F4832AB35F</gtr:id><gtr:title>Epigenetic restriction of embryonic cell lineage fate by methylation of Elf5.</gtr:title><gtr:parentPublicationTitle>Nature cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f2c881100e23b0e46b19412580ca110c"><gtr:id>f2c881100e23b0e46b19412580ca110c</gtr:id><gtr:otherNames>Ng RK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1465-7392</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3D6551C8-0898-4F8B-A432-988998671140"><gtr:id>3D6551C8-0898-4F8B-A432-988998671140</gtr:id><gtr:title>Epigenetic dynamics of stem cells and cell lineage commitment: digging Waddington's canal.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Molecular cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4843181f21764df7133f54d6d304065d"><gtr:id>4843181f21764df7133f54d6d304065d</gtr:id><gtr:otherNames>Hemberger M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1471-0072</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/76772B55-BCC4-4955-AE16-1DC6A8DC1A47"><gtr:id>76772B55-BCC4-4955-AE16-1DC6A8DC1A47</gtr:id><gtr:title>Promoter DNA methylation couples genome-defence mechanisms to epigenetic reprogramming in the mouse germline.</gtr:title><gtr:parentPublicationTitle>Development (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/beef200c9252b10229a52a6fd2b95d12"><gtr:id>beef200c9252b10229a52a6fd2b95d12</gtr:id><gtr:otherNames>Hackett JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0950-1991</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1515162F-F3B0-4D02-819D-72EDAD09D516"><gtr:id>1515162F-F3B0-4D02-819D-72EDAD09D516</gtr:id><gtr:title>NANOG-dependent function of TET1 and TET2 in establishment of pluripotency.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8a49df4fdaf06544f5fd0ebb587420e7"><gtr:id>8a49df4fdaf06544f5fd0ebb587420e7</gtr:id><gtr:otherNames>Costa Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CDF899AA-263A-4868-8BF4-F4F8FBDA1853"><gtr:id>CDF899AA-263A-4868-8BF4-F4F8FBDA1853</gtr:id><gtr:title>5-Hydroxymethylcytosine in the mammalian zygote is linked with epigenetic reprogramming.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4adf370b898716761a79b3fc043c6b98"><gtr:id>4adf370b898716761a79b3fc043c6b98</gtr:id><gtr:otherNames>Wossidlo M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/85B544A6-85C3-426C-B5E5-BCD1E4B9D719"><gtr:id>85B544A6-85C3-426C-B5E5-BCD1E4B9D719</gtr:id><gtr:title>A screen for hydroxymethylcytosine and formylcytosine binding proteins suggests functions in transcription and chromatin regulation.</gtr:title><gtr:parentPublicationTitle>Genome biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/24ff68b97795cbe6d9de45a4d8adda78"><gtr:id>24ff68b97795cbe6d9de45a4d8adda78</gtr:id><gtr:otherNames>Iurlaro M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1474-7596</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0AAA8D44-3E1E-4930-BFBF-AA97D7752AE6"><gtr:id>0AAA8D44-3E1E-4930-BFBF-AA97D7752AE6</gtr:id><gtr:title>Regulation of lineage specific DNA hypomethylation in mouse trophectoderm.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fbf06246c03e5d725029548b34bea1f1"><gtr:id>fbf06246c03e5d725029548b34bea1f1</gtr:id><gtr:otherNames>Oda M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0700098</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>